Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Caregiver Burden Within the Ambulatory Extended Recovery (AXR) Patient Population
- Conditions
- Caregiver Burden
- Interventions
- Behavioral: Caregiver Reaction Assessment (CRA)Behavioral: The Caregiver Quality of Life - Cancer (CQOLC)
- First Posted Date
- 2015-07-17
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 47
- Registration Number
- NCT02501785
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid Tumors
- Conditions
- Solid Tumors
- Interventions
- Procedure: Production of Genetically-modified T cellsDevice: IP Catheter InsertionGenetic: Infusion of 4H11-28z/fIL-12/EGFRt+ Genetically-modified T cells
- First Posted Date
- 2015-07-15
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT02498912
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis
- Conditions
- Lung CancerLung Metastases
- Interventions
- First Posted Date
- 2015-07-14
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 34
- Registration Number
- NCT02496585
- Locations
- 🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older
- Conditions
- Acute Lymphoblastic Leukemia
- Interventions
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT02494882
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer
- Conditions
- High Risk for Developing Breast Cancer
- Interventions
- Behavioral: Nonlinear Aerobic TrainingOther: Height, Weight, BMI measureOther: Blood drawOther: Cardiopulmonary exercise test
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT02494869
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Immunotherapy for the Treatment of Breast Cancer Related Upper Extremity Lymphedema (BCRL)
- First Posted Date
- 2015-07-10
- Last Posted Date
- 2018-11-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT02494206
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
- Conditions
- Epithelial Ovarian Cancer
- Interventions
- Device: Mirena® intra-uterine device (IUD)
- First Posted Date
- 2015-06-22
- Last Posted Date
- 2023-10-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 7
- Registration Number
- NCT02477202
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Commack, Commack, New York, United States
Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers
- Conditions
- Metastatic Disease to BoneMetastatic Disease to Soft Tissue
- Interventions
- Device: MRI with IVIM DW-MRIOther: Blood draw
- First Posted Date
- 2015-06-08
- Last Posted Date
- 2016-09-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT02465723
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI
- Conditions
- Screening Breast MRI in Patients Who Are BRCA Mutation Carriers
- Interventions
- Device: MRIBehavioral: Optional Screening Questionnaire
- First Posted Date
- 2015-06-04
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 63
- Registration Number
- NCT02462460
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Irreversible Electroporation Ablation for Colorectal Metastases to the Lung
- Conditions
- Colorectal Metastases to the Lung
- Interventions
- Device: Irreversible Electroporation Ablation
- First Posted Date
- 2015-06-03
- Last Posted Date
- 2018-01-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT02461550
- Locations
- 🇺🇸
Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸Memorial Sloan Kettering West Harrison, Harrison, New York, United States